1NWS
TAK icon

1 North Wealth Services’s Takeda Pharmaceutical TAK Stock Holding History

1 North Wealth Services’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4K Hold
221
– – ﹤0.01% 277
2019
Q3 		$4K Buy
+221
New +$3.82K ﹤0.01% 235
2019
Q1 		$5K Buy
+221
New +$4.45K ﹤0.01% 202

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

1 North Wealth Services's TAK Position: Q4 2019 in Review

1 North Wealth Services held its Takeda Pharmaceutical (TAK) position steady in Q4 2019 at 221 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #277.

1 North Wealth Services first reported a position in TAK in Q1 2019 and has held it in 3 quarters since. The position peaked at $5K in Q1 2019. 339 funds tracked by Wall St. Rank hold TAK as of Q4 2019.

  • 1 North Wealth Services held 221 shares of Takeda Pharmaceutical worth $4K as of Q4 2019.
  • 1 North Wealth Services left its Takeda Pharmaceutical share count unchanged in Q4 2019.
  • Takeda Pharmaceutical made up ﹤0.01% of 1 North Wealth Services's portfolio in Q4 2019, its #277 holding.
  • 1 North Wealth Services first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 3 quarters since.
  • 1 North Wealth Services's Takeda Pharmaceutical position peaked at $5K in Q1 2019.
  • 339 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2019.

Based on 1 North Wealth Services's 13F filing for Q4 2019, filed 14 Feb 2020.